Short Bowel Syndrome Market to Become a Worth US $2.6 Bn by the End 2024
The global Short Bowel Syndrome Market is consolidated. Shire Plc. held 50% of the market in 2015. Strategic acquisitions have become a strategy for key players. The players are also focused on marketing over-the-counter dietary supplements over-the-counter dietary supplements as well as manufacturing these supplements. Companies are also focusing on developing Innovative Therapies which Focus majorly on gastrointestinal diseases, states Transparency Market Research in its latest research on the global short bowel syndrome market.
View full press release